These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23999392)

  • 1. Production and biomedical applications of virus-like particles derived from polyomaviruses.
    Teunissen EA; de Raad M; Mastrobattista E
    J Control Release; 2013 Nov; 172(1):305-321. PubMed ID: 23999392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological cross-reactions between four polyomaviruses of birds using virus-like particles expressed in yeast.
    Zielonka A; Gedvilaite A; Reetz J; Rösler U; Müller H; Johne R
    J Gen Virol; 2012 Dec; 93(Pt 12):2658-2667. PubMed ID: 22933666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
    Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
    BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells.
    Gedvilaite A; Dorn DC; Sasnauskas K; Pecher G; Bulavaite A; Lawatscheck R; Staniulis J; Dalianis T; Ramqvist T; Schönrich G; Raftery MJ; Ulrich R
    Virology; 2006 Oct; 354(2):252-60. PubMed ID: 16904154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae.
    Sasnauskas K; Bulavaite A; Hale A; Jin L; Knowles WA; Gedvilaite A; Dargeviciūte A; Bartkeviciūte D; Zvirbliene A; Staniulis J; Brown DW; Ulrich R
    Intervirology; 2002; 45(4-6):308-17. PubMed ID: 12602348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast.
    Norkiene M; Stonyte J; Ziogiene D; Mazeike E; Sasnauskas K; Gedvilaite A
    BMC Biotechnol; 2015 Aug; 15():68. PubMed ID: 26239840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation of DNA and non-viral protein changes the structure of murine polyomavirus virus-like particles.
    Lipin DI; Chuan YP; Lua LH; Middelberg AP
    Arch Virol; 2008; 153(11):2027-39. PubMed ID: 18979257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.
    Tegerstedt K; Franzén AV; Andreasson K; Joneberg J; Heidari S; Ramqvist T; Dalianis T
    Anticancer Res; 2005; 25(4):2601-8. PubMed ID: 16080500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine pneumotropic virus VP1 virus-like particles (VLPs) bind to several cell types independent of sialic acid residues and do not serologically cross react with murine polyomavirus VP1 VLPs.
    Tegerstedt K; Andreasson K; Vlastos A; Hedlund KO; Dalianis T; Ramqvist T
    J Gen Virol; 2003 Dec; 84(Pt 12):3443-3452. PubMed ID: 14645925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hamster Polyomavirus Research: Past, Present, and Future.
    Jandrig B; Krause H; Zimmermann W; Vasiliunaite E; Gedvilaite A; Ulrich RG
    Viruses; 2021 May; 13(5):. PubMed ID: 34068409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial production of virus-like particle vaccine protein at gram-per-litre levels.
    Liew MW; Rajendran A; Middelberg AP
    J Biotechnol; 2010 Oct; 150(2):224-31. PubMed ID: 20797415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative characterization of virus-like particles by asymmetrical flow field flow fractionation, electrospray differential mobility analysis, and transmission electron microscopy.
    Pease LF; Lipin DI; Tsai DH; Zachariah MR; Lua LH; Tarlov MJ; Middelberg AP
    Biotechnol Bioeng; 2009 Feb; 102(3):845-55. PubMed ID: 18958863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
    Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
    Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Presumed Polyomavirus Viroporin VP4 of Simian Virus 40 or Human BK Polyomavirus Is Not Required for Viral Progeny Release.
    Henriksen S; Hansen T; Bruun JA; Rinaldo CH
    J Virol; 2016 Nov; 90(22):10398-10413. PubMed ID: 27630227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of self-assembled virus-like particles of Merkel cell polyomavirus.
    Li TC; Iwasaki K; Katano H; Kataoka M; Nagata N; Kobayashi K; Mizutani T; Takeda N; Wakita T; Suzuki T
    PLoS One; 2015; 10(2):e0115646. PubMed ID: 25671590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological cross reactivity between polyomavirus capsids.
    Viscidi RP; Clayman B
    Adv Exp Med Biol; 2006; 577():73-84. PubMed ID: 16626028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope.
    Mazeike E; Gedvilaite A; Blohm U
    Virus Res; 2012 Jan; 163(1):2-10. PubMed ID: 21864590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus.
    Viscidi RP; Rollison DE; Sondak VK; Silver B; Messina JL; Giuliano AR; Fulp W; Ajidahun A; Rivanera D
    Clin Vaccine Immunol; 2011 Oct; 18(10):1737-43. PubMed ID: 21880855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.